Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 34.5309
- Book/Share 7.6894
- PB 5.3008
- Debt/Equity 1.9556
- CurrentRatio 3.094
- ROIC 0.0925
- MktCap 1652174563.0
- FreeCF/Share 0.8459
- PFCF 48.1852
- PE 24.3625
- Debt/Assets 0.4399
- DivYield 0.0118
- ROE 0.2443
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PAHC | JP Morgan | Neutral | Overweight | -- | $35 | July 7, 2025 |
| Upgrade | PAHC | BNP Paribas Exane | Underperform | Neutral | -- | $24 | June 16, 2025 |
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like PAHC, ATRO, COMM and HRTG are seeing price strength and have a high chance of carrying the momentum forward.
Read More
Best Momentum Stock to Buy for Nov. 20th
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC, SHIP and BCAL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2025.
Read More
Best Income Stocks to Buy for Nov. 20th
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
SHIP, PAHC and FCFS made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 20, 2025.
Read More
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript
Published: November 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.
Read More
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
Published: October 30, 2025 by: Business Wire
Sentiment: Neutral
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation is proud to announce the national launch of Restoris™ piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs with periodontal disease. Developed in collaboration with a leading U.S. dental school and licensed to Phibro, Restoris represents a breakthrough in veterinary dental care, offering a dual mechanism of action to restore oral health at its foundation. The launch of Re.
Read More
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Read More
New Strong Buy Stocks for September 30th
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive
UGP, PDS, FUTU, PAHC and PGY have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2025.
Read More
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It?
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC rallies 82% YTD with booming vaccines, MFAs and global expansion fueling investor confidence.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock
Published: September 22, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Phibro Animal Health (PAHC) Is Up 0.43% in One Week: What You Should Know
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
Published: September 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
Read More
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
Published: September 02, 2025 by: Seeking Alpha
Sentiment: Positive
Phibro Animal Health Corporation's Zoetis MFA acquisition has revitalized its overall growth. Animal Health is now around 75% of their total sales, and its integration should be finalized by Q4 2025. Post-integration, PAHC believes Zoetis MFAs will normalize to flat growth. But, Vaccines and Nutritional Specialties should continue growing at double digits. PAHC's Phibro Forward initiative is also adding new efficiencies in procurement, commercial, and process improvements.
Read More
Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript
Published: August 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2025 Earnings Conference August 28, 2025 9:00 AM ET Company Participants Daniel M. Bendheim - Executive VP of Corporate Strategy & Director Glenn C.
Read More
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Best Growth Stocks to Buy for July 23rd
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC, AFYA and ROAD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 23, 2025.
Read More
Best Value Stocks to Buy for July 23rd
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
NX, OPBK and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2025.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jack Clifford Bendheim
- Employees 1940